EPISODE · Jun 23, 2021 · 12 MIN
Why Is There No Food and Drug Administration–Approved Medication for Major Depression With Psychotic Features?
from The Journal of Clinical Psychopharmacology Podcast
Psychotic depression is a severely disabling illness and is more common than is generally realized. Unfortunately, there is no FDA-approved medication for its treatment. In this podcast, the Editor-in-Chief of the Journal of Clinical Psychopharmacology, Anthony J. Rothschild, discusses his opinions as to how this came about and encourages further research and development of a suitable medication with an eye toward FDA approval.
NOW PLAYING
Why Is There No Food and Drug Administration–Approved Medication for Major Depression With Psychotic Features?
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.